Application Of Enzymes In Medical Diagnosis

With the development of biotechnology in the modern information age, humans have conducted more and more in-depth research and development on enzymes. Correspondingly, the application of enzymes in medicine has become more and more extensive. Through a review of recent research papers on the application of enzymes in medicine, it provides certain technical guidance and references for further research on enzymes in human and animal medicine. This article summarizes the application of some enzymes in the diagnosis, treatment and prevention of diseases from the aspects of enzymatic diagnosis and medicinal enzymes, confirming the indispensable importance and significance of diagnostic enzyme in our lives.

  1. Application of enzymes in disease diagnosis

Enzymology diagnosis is a method to determine the content and changes of certain substances in the body through the catalytic action of enzymes, and to diagnose diseases through changes in the original enzyme activity in the body. Under pathological conditions, when cells are damaged, the enzyme in the cells will be released into body fluids, so the activity and content of enzymes in body fluids can be measured for disease diagnosis. And because of the high efficiency and specificity of enzyme catalysis, the enzymatic diagnosis method is reliable, simple and fast, and has been widely used in clinical diagnosis.

The enzyme detection method mainly detects its activity through the enzyme activity level and the enzyme activity ratio. In general, the content of certain enzymes in the body fluids of healthy people is relatively constant, but when some diseases occur, the activity levels of certain enzymes in the body fluids will change greatly. Therefore, it is possible to make a preliminary judgment on the occurrence and location of the disease by measuring the activity level of specific enzymes in body fluids. The enzyme activity level and the area under the enzyme activity time curve are related to the extent or amount of tissue cell damage. If the enzyme activity increases in a large amount, it indicates a large amount of tissue damage, such as liver and skeletal muscle. The severity of cell damage can be expressed by the ratio of mitochondrial and cytoplasmic enzyme activities. Severe cell damage or necrosis will cause enzymes in mitochondria to be released into the blood, such as m-AST and glutamate dehydrogenase (GLDH) in mitochondria.

Plasma enzyme levels are only obtained through a special structure or tissue in the same organ, and the enzyme activity produced in all cells of the organ is roughly the same. For example, the activity of ALT, ?-glutamyl transpeptidase (GGT) or GLDH is related to aminotransferase in liver disease, and the ratio of these enzymes can be used for differential diagnosis in acute liver disease. In addition, within a certain range, the ratio of AST/ALT can also reflect the severity and severity of chronic hepatitis. However, when the liver is damaged to a certain degree, the sensitivity of enzymatic detection will be affected.

There are some specific enzymes in different tissues or organs of the human body (these enzymes are mainly synthesized in a certain tissue or organ, but rarely come from other tissues). When a certain disease occurs or cell tissue is damaged, these cells are destroyed, and the synthesis of specific enzymes is reduced and the activity is reduced. Therefore, we can determine the location of disease or cell damage by detecting the activity of some specific enzymes corresponding to a certain organ or tissue contained in body fluids. For example, serum cholinesterase (CHE) is a non-specific esterase that is synthesized by liver cells and released into the blood. When liver cells are diseased or the intestinal-hepatic circulation is impaired, the synthesis of CHE decreases and the activity decreases.

  1. Application of enzymes in disease treatment and prevention

Enzymes can be used as drugs to treat many diseases, and enzymes used as drugs for disease treatment and prevention are called medicinal enzymes. As a molecular-level therapeutic drug, enzyme preparations have the characteristics of specificity, high efficiency, and low toxic and side effects. They play an important role in preventing and treating diseases and anti-aging. Fibrinolytic enzymes are proteins with biological activity, which can activate the fibrinolytic system in the body and promote fibrinolysis. They are widely used clinically in the treatment of myocardial infarction and various thrombotic diseases.

Many scholars have isolated fibrinolytic active substances from the metabolites of microorganisms, such as Streptocolcus Hemolytius, Streptokinase, Staphylococcus aureus, Staphylokinase and Nattokinase.

  1. Application of enzyme catalysis process in pharmacy

Enzyme catalysis, as an important part of chiral technology and green chemistry, has been applied to the production of some chemical drugs in the pharmaceutical industry. In addition, the enzyme catalysis process has the characteristics of green, high efficiency, mild action conditions, and can be carried out in the water phase, and has high regioselectivity and stereoselectivity.

In conclusion, traditional chemical process pharmacy has the disadvantages of consumables, time-consuming and labor-intensive, and waste generation. Gradually people began to study biotechnology pharmacy, and the main research object of using biotechnology pharmacy was enzymes. Enzyme reaction has the characteristics of specificity and high efficiency, which can be used for targeted diagnosis and treatment of diseases. It uses the characteristics of specific enzyme catalysis, high efficiency and mild action conditions to produce drugs, and has the advantage of small side effects. This shows that enzymes lie in our lives and have extremely important meaning and status. However, when using enzyme-catalyzed technology to manufacture drugs, it is necessary to know that different enzymes require different reaction conditions. Therefore, the application of more reasonable and easy-to-operate enzyme reactors for industrial production of drugs needs to continue in-depth development and research.

Creative Enzymes is a worldwide leading company in diagnostic enzymes manufacturing and supply, committed to providing customers with diverse enzyme products and custom enzyme-related services for medical and research diagnosis. Relying on professional team and state-of-art technologies, Creative Enzymes have gained solid reputation for having top of the line products and services. The product lines cover a wide range of application areas, including but not limited to blood lipids, liver function, kidney and pancreas function, diabetes, POCT bio-sensor and clinical diagnosis. Every product is presented with detailed description, source, form, activity and other biochemical properties.

Angiography is an imaging procedure which provides visualization of blood vessel to detect narrow, blocked, enlarged arteries or veins in the body. Local or general anesthesia has been given to the patient during angiography procedure. This procedure uses various imaging technologies such as, Magnetic Resonance Imaging, Computed Tomography, X-ray and others. The superior quality of angiography imaging over conventional techniques is increasing the adoption of angiography devices especially for heart related disorders. The MRI and CT angiography devices would be the most prominent products in this market owing to its efficacy, minimal side effects and short duration in terms of outcome. Commercialization of high end imaging technologies and increasing affordability of patients has increases the scope of hybrid angiography devices, in developed region. The demand for angiography devices in developing region would get reduced owing to its relatively saturated market situation. This market would be further driven by replacement of old devices.

Angiography Devices Market: Drivers and Restraints

Increasing CVD incidences, growing number of geriatric population, dysfunctional lifestyle, growing demand for sophistication diagnostic procedures are driving the growth of angiography devices market, globally. Also, the rising awareness for cardiovascular disease diagnosis and treatment, favorable government regulation to commercialize angiography devices are the additional factors fueling the growth of angiography devices market. However, the high cost angiography devices, lack of reimbursement, and unaffordability across emerging economies are some of the factors impeding the market growth. However, the companies operating in this market are actively focusing on the commercialization of low cost system to grab the highest market share in emerging economies.

Browse Full Report@

Angiography Devices Market: Segmentation

The global angiography devices market is segmented based on, device, product type, application, procedures, end use and indication.

Based on devices, the global angiography devices market is segmented into the following:

  • Magnetic Resonance Angiography (MRA)
  • Computed Tomography Angiography (CTA)
  • Conventional Angiography

Based on procedure, the global angiography devices market is segmented into the following:

  • Coronary Angiography
  • Pulmonary Angiography
  • Cerebral Angiography
  • Extremity Angiography
  • Renal Angiography

Based on end users, the global angiography devices market is segmented into the following:

  • Hospitals and Surgical Centers
  • Diagnostics Centers
  • Academic and Research Institutes

Based on indication, the global angiography devices market is segmented into the following:

  • Coronary Artery Disease (CAD)
  • Congenital Heart Disease
  • Congestive Heart Failure
  • Kidney Disorders
  • Others

Request Free Report Sample@

Angiography Devices Market: Overview

By device, the angiography device market was dominated by more advanced technologies such as MRI and CT, owing to their high efficiency over conventional technologies. Recently launched, Real-time 3D echocardiography by Siemens Healthcare is one of the key development in angiography devices market, which is used to diagnose various heart and coronary conditions. By procedure, coronary angiography and pulmonary angiography are the dominating procedure, owing to its high prevalence. By end-users, hospitals and surgical centers hold promising share, followed by diagnostic centers. This is due to premium pricing of angiography devices, which is unaffordable for the medium scale diagnostic centers. By disease indication, Coronary Artery Disease (CAD) is the leading segment due to its high incidence and absence of alternative diagnostic technique.

Angiography Devices Market: Region-wise Outlook

North America was the lading region for angiography devices in terms of revenue in 2015, followed by Europe. Increasing incidence of coronary disorder owing to dysfunction lifestyle is the prime factor driving the growth of angiography device market in these region. However, the similar kind of trend is now shifting towards emerging economies which is expected to create notable growth opportunity for the angiography device during the forecast period.

Request For TOC@

Angiography Devices Market: Key Players

Leading players operating in angiography devices includes, Shimadzu Corporation, Royal Philips Electronics, Siemens Healthcare, GE Healthcare, Toshiba Medical System Corporation, Shimadzu Corporation, St. Jude Medical, Inc., Toshiba Medical Systems Corporation, Cordis Corporation, Medtronic, Inc., and Abbott Vascular (Abbott Laboratories). Companies operating in this market are seeking for novel product to gain core competencies in the market. These companies are also conducting collaborative studies with the clinical research institutes to sustain their market position.